Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO) in a report issued on Wednesday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Down 58.3 %

Shares of CO stock opened at $0.25 on Wednesday. The stock has a market cap of $30.39 million, a price-to-earnings ratio of 0.39 and a beta of 0.16. The business’s fifty day moving average is $1.05 and its 200 day moving average is $1.33. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.